Track the 선바이오 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 선바이오 has published 10 insider filings. Market capitalisation: €78.7bn. The latest transaction was reported on 23 April 2026 (Purchase). Among the most active insiders: 노광. All data is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€32,402
10 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
Buys €32,402n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,793 of 29,064 companies
56.7
score / 100
Value
44
Quality
70
FCF yld0.8%
Earn yld3.8%
EV/EBITDA17.2x
ROE35%
Gross mgn61%
Net mgn20%
Debt/EBITDA4.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.